US FDA approves Schering-Plough's Avelox to treat intra-abdominal infections in adults
Thursday, December 01, 2005 17:00 IST Kenilworth
Schering-Plough Corporation has received an approval from the US Food and Drug Administration for the once-daily, broad-spectrum antibiotic Avelox (moxifloxacin HCl)